Sequella, Inc.
Statement From Sequella Founder and CEO, Dr. Carol Nacy at the 'Stop TB' Meeting in Brazil on the Eve of World TB Day
Published in AIDS Weekly, April 6th, 2009
"With multidrug (MDR) and extremely drug (XDR) resistant tuberculosis on the rise, the world-wide financial crisis is of major concern to the international health community," said Dr. Carol Nacy, CEO of Sequella. "The Global Fund to fight HIV, malaria, and TB is running a huge deficit, and public health officials fear that any gains of the last 10 years in control of TB, especially in HIV-infected patients, will be lost. The specter of untreatable TB hangs like a pall over the STOP TB Partnership meeting in Rio de Janeiro, as patient advocates and health ministers, companies and non-governmental organizations, gather to determine how best to work together to even maintain the status...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2009-04-06)
More Articles from AIDS Weekly
- Albert Einstein College of Medicine
Einstein and Pitt researchers develop new TB test that will dramatically cut diagnosis time - Antiretrovirals
Research reports on antiretrovirals from A. Kiboneka and colleagues provide new insights - Biotechnology Business
New biotechnology business findings from T.J. Wilkin and co-authors described - HIV/AIDS
Findings from A. Streinucercel et al in HIV/AIDS reported - HIV/AIDS
New findings from Vall d'Hebron University describe advances in HIV/AIDS - HIV/AIDS
New HIV/AIDS findings from University of Richmond described - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
